01 · Collect
Ingest the evidence base.
Trials, research text, molecular databases, de-identified records, and insurance claims — continuously.
Sectors / Medical
Trials, research text, molecular data, and insurance claims that quietly disagree — and evidence skewed toward populations that don't represent everyone. The answer a clinician needs is buried in the noise.
Medicine generates more knowledge than any human can hold — trials, molecular data, clinical text, and hundreds of millions of insurance claims — and much of it quietly contradicts itself. Retractions, underpowered studies, and publication bias leave a literature that is vast, authoritative-sounding, and unreliable.
So we collect the data, the research text, and the claims, and ask whether what we believe is actually true. Is a disease chemical, environmental, or genetic? Does a result hold across ancestries, or only in the group that was studied? Racial and demographic diversity isn't a footnote — a treatment proven in one population can fail in another. Answering that is a knowledge-engineering problem.
Questions Worth a Clean Answer
The Method — A Continual Loop
01 · Collect
Trials, research text, molecular databases, de-identified records, and insurance claims — continuously.
02 · Refine
Weak power, contradiction, and retracted findings stripped out. What survives agrees with itself.
03 · Hypothesize
The core proposes drug–gene–phenotype links that no single study reported but all of them imply.
04 · Test
Predictions validated on new trials, held-out cohorts, and real-world outcomes.
05 · Refine
Results fold back in. Every cycle it gets more predictive and less credulous. Continual.
The Cascade
How compounds discovered for one indication cascade through their real mechanisms into unexpected therapeutic uses — and reshape entire markets. A map of serendipity turned into pipeline strategy for 2026.
Select any node to trace its chain. Left to right: Compound / insight → Mechanism → Repurposed use → Industry shift.
What the Core Delivers